Library
Agency issuances
16,884 issuances · 1941–2026
12 issuances in 2013 by Benigno S. Aquino III
Newest first
- FDA Circular No. 2013-029 FILING OF APPLICATIONS FOR LICENSING OF TOY ESTABLISHMENTS AND REGISTRATION OF TOY PRODUCTS TO THE CENTER FOR COSMETIC REGULATION AND RESEARCH THROUGH THE FDA-PAIR UNIT
- FDA Circular No. 2013-027 WAIVER OF INITIAL AND RENEWAL APPLICATION FEES FOR LICENSE TO OPERATE AS DRUG OUTLETS OR PHARMACIES IN CALAMITY AREAS IN LEYTE AND EASTERN SAMAR UNTIL DECEMBER 31, 2014, AND FOR OTHER PURPOSES
- FDA Circular No. 2013-028 SUSPENSION OF MANUFACTURE, IMPORTATION, DISTRIBUTION, AND/OR MARKETING OF KETOCONAZOLE ORAL PRODUCTS
- FDA Circular No. 2013-026 ADOPTION OF THE ICH HARMONISED TRIPARTITE GUIDELINE, QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS Q5C
- FDA Circular No. 2013-025 AMENDMENT OF THE CERTIFICATE/S OF PRODUCT REGISTRATION (CPRS) OF DRUG PRODUCTS
- FDA Circular No. 2013-024 ADOPTION AND IMPLEMENTATION OF “THE MEXICO CITY PRINCIPLES FOR VOLUNTARY CODES OF BUSINESS ETHICS IN THE BIOPHARMACEUTICAL SECTOR”
- FDA Circular No. 2013-023 CLARIFICATION ON THE PROVISIONS OF ADMINISTRATIVE ORDER NO. 2013-0022, ON THE GUIDELINES FOR CURRENT GOOD MANUFACTURING PRACTICE (cGMP) CLEARANCE AND INSPECTION OF FOREIGN DRUG MANUFACTURERS
- FDA Circular No. 2013-022 GUIDELINES ON HANDLING CONSUMER COMPLAINTS
- FDA Circular No. 2013-021 COMPARATOR DRUGS FOR SELECTED PHARMACEUTICAL PRODUCTS CONTAINING BIOPHARMACEUTICS CLASSIFICATION SYSTEM (BCS) CLASS 4 DRUG MOLECULES
- FDA Circular No. 2013-020 REITERATION OF REGISTRATION OF HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS
- FDA Circular No. 2013-019 ORGANIZATION OF THE ASEAN COMMON TECHNICAL DOSSIER (ACTD) FOR THE REGISTRATION OF PHARMACEUTICAL PRODUCTS FOR HUMAN USE
- FDA Circular No. 2013-018 ADOPTION OF THE INTERNATIONAL CONFERENCE ON HARMONIZATION (ICH) SAFETY AND EFFICACY GUIDELINES